HLTHTema Healthcare AI ETF
Seeks to provide long-term growth.
By Tema ETFs · Launched 2026
Annual Cost
0.75%
#4,061 of 6,033 · expensive
Fund Size
$8M
#5,112 of 6,033 · small
Return (1Y)
-89.2%
Track Record
2 months
#5,912 of 6,033 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,131+11.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
GlobalCap
Multi cap
Strategy
Active selection
Sector
Health careFocus
Artificial Intelligence
Holdings
By weightConcentration
Top 10 holdings = 48.1% of fundmoderately concentrated
10x Genomics Inc Ordinary Shares - Class ATXG
6.7%
Twist Bioscience CorpTWST
5.9%
Illumina IncILMN
5.0%
Cytokinetics IncCYTK
4.9%
Revolution Medicines Inc Ordinary SharesRVMD
4.7%
Natera IncNTRA
4.6%
Vertex Pharmaceuticals IncVRTX
4.5%
Cogent Biosciences IncCOGT
4.3%
Intuitive Surgical IncISRG
4.0%
DexCom IncDXCM
3.7%
Asset allocation
Stocks
99.5%
Cash
0.6%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
126.3%High
Year-on-year price swings
Max drawdown
-99.8%Severe
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks to provide long-term growth.
- Strategy
- Actively manages a portfolio investing at least 80% in common and preferred stocks of domestic and foreign Healthcare AI companies across micro-, small-, medium-, and large-capitalization. Focuses on companies applying AI to healthcare, aiming for long-term growth.
- Inception date
- July 20, 2026
- Fund family
- Tema ETFs
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save HLTH to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-16